PRESS RELEASE published on 01/24/2024 at 08:30, 9 months 29 days ago Transaction in Own Shares Nordea Bank Abp has completed the repurchase of its own shares on 23.01.2024 in accordance with the share buy-back programme announced on 26 April 2023. The transactions were executed in public trading as regulated by the European Parliament and Council. After the completion of these transactions, Nordea holds a certain number of treasury shares for capital optimisation and remuneration purposes. For further information, please contact the provided Investor Relations and Media inquiries contacts. Investor Relations Treasury Shares Nordea Bank Abp Share Buy-back Programme European Parliament And Council Regulations
PRESS RELEASE published on 01/23/2024 at 08:35, 9 months 30 days ago Transaction in Own Shares Nordea Bank Abp has announced the completion of the repurchase of its own shares in public trading, in line with the share buy-back programme authorized by Nordea's Annual General Meeting 2023. The transactions were executed in accordance with the relevant regulations, resulting in Nordea holding a specified number of treasury shares for capital optimization and remuneration purposes. Treasury Shares Nordea Bank Abp Share Buy-back Programme Repurchase Public Trading
PRESS RELEASE published on 01/22/2024 at 08:00, 10 months ago Nordea Bank Abp: Repurchase of own shares on 19.01.2024 Nordea Bank Abp has completed the repurchase of its own shares on 19.01.2024 as part of a share buy-back program. The transactions were executed in public trading and in accordance with relevant regulations. After the disclosed transactions, Nordea holds treasury shares for capital optimisation and remuneration purposes. For further information, investors and media can contact the provided representatives. Investor Relations Treasury Shares Nordea Bank Abp Share Buy-back Program Stock Exchange
PRESS RELEASE published on 11/10/2023 at 08:20, 1 year ago Nordea Bank Abp: Repurchase of own shares on 09.11.2023
PRESS RELEASE published on 11/06/2023 at 17:25, 1 year ago Nordea Bank Abp flagging notification: BlackRock Inc.'s shareholding crosses threshold of five percent
PRESS RELEASE published on 11/03/2023 at 16:45, 1 year ago Nordea Bank Abp flagging notification: BlackRock Inc.'s shareholding decreases below threshold of five percent
Published on 11/22/2024 at 18:45, 2 hours 42 minutes ago CORRECTING and REPLACING the Not-So-Secret Lives of REAL "Mormon" Wives - the Eye-Opening New Book From Cedar Fort Publishing & Media - is Now Available for Purchase, Just in Time for Christmas
Published on 11/22/2024 at 16:00, 5 hours 27 minutes ago Manimal Tales Unveils Two New Personalized Christmas-Themed Books to Spread Holiday Magic and Joy!
Published on 11/22/2024 at 15:55, 5 hours 32 minutes ago Independent Proxy Advisory Firm ISS Recommends Signal Gold Shareholders Vote for Arrangement Resolution and Private Placement Resolution
Published on 11/22/2024 at 15:15, 6 hours 12 minutes ago Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Published on 11/22/2024 at 14:45, 6 hours 42 minutes ago Jaguar Health Seeking Partner to Develop and Commercialize NP300 Second-Generation Antisecretory Prescription Drug Candidate for Treatment of General Diarrhea in Dogs
Published on 11/22/2024 at 18:14, 3 hours 13 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 3 hours 34 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 4 hours 32 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 5 hours 27 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 1 day 14 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 2 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 3 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 3 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024